Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its 2026 priorities across its five growth pillars focused on advancing product commercialization, regulatory milestones and ...

QuantiFERON: Accelerating workflow automation and AI-related investments QIAGEN is developing a fifth generation of its QuantiFERON test, with updates planned during 2026 as part of its commitment to ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in 2028 QIAGEN N.V. (NYSE: ...

The five pillars – Sample technologies, QIAstat-Dx syndromic testing, QIAcuity digital PCR, QIAGEN Digital Insights (QDI) bioinformatics and QuantiFERON for latent tuberculosis testing – represent ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in 2028 VENLO, Netherlands, ...

President Trump's comments about restarting weapons tests are not likely to lead to mushroom-cloud explosions over the New Mexico desert or seismic shaking underground in Nevada, according to the ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...

The president's announcement that the U.S. would resume tests leaves questions. President Donald Trump raised questions Wednesday night about a decades-old U.S. prohibition on testing its nuclear ...

President Trump explained the order by saying other, unnamed nations were testing their own nuclear weapons, even though no country has tested since 2017. By David E. Sanger and William J. Broad David ...